• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number HT066080A
Device Problem Occlusion Within Device (1423)
Patient Problems Embolism (1829); Occlusion (1984); Claudication (2550)
Event Date 04/20/2014
Event Type  Injury  
Event Description
In (b)(6) 2014, the patient presented with claudication.Bilateral external iliac artery and superficial femoral artery occlusions were identified.On (b)(6) 2014, two gore viabahn endoprostheses were implanted.On (b)(6) 2014, angiogram revealed filling defects and embolization with an occlusion of the viabahn device.The physician suspected the embolization was due to a previous myocardial infarction.(b)(6) 2014, axillobifemoral gore-tex stretch vascular graft was implanted to bypass the occluded iliac vessels including the right external iliac artery where the viabahn devices were implanted.Distal anastomosis of the axillobifemoral stretch vascular graft was at the profunda artery bilaterally.A right above the knee femoral-popliteal bypass graft was also implanted using a gore propaten vascular graft.The axillobifemoral gore-tex stretch graft occluded on (b)(6) 2014.A thrombectomy was performed to treat the vascular graft occlusion.The propaten graft was explanted and replaced with a removable ring gore-tex vascular graft.No report of an graft occlusion involving the propaten vascular graft was received.
 
Manufacturer Narrative
Evaluation in progress pending the completion of the manufacturing paperwork review.This event involved four gore devices: viabahn endoprosthesis - lot #12045257, mfr report #2017233-2014-00257; viabahn endoprosthesis - lot #12091352, mfr report #2017233-2014-00258; gore-tex stretch vascular graft - lot #11687160, mfr report #3006215353-2014-00001; gore propaten vascular graft - lot #4259301pp001, mfr report #2017233-2014-00259.
 
Manufacturer Narrative
Review of the manufacturing paperwork has been conducted.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
roger smith
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3819414
MDR Text Key4496917
Report Number2017233-2014-00259
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue NumberHT066080A
Device Lot Number4259301PP001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/19/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/06/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/26/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-